Plasma PZP level elevation: a potential correlate of diabetic kidney disease progression
-
By
-
Lin Mao
-
Ruili Yin
-
Longyan Yang
-
Dong Zhao
-
May 28, 2026
-
Clinical Scorecard: Increased Plasma Levels of Pregnancy Zone Protein as a Possible Indicator of Progression in Diabetic Kidney Disease
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Increased plasma levels of pregnancy zone protein (PZP) correlate with DKD progression. [Needs source] |
| Target Population | |
| Care Setting | |
Key Highlights
- Remove the statement about PZP as a potential biomarker.
Guideline-Based Recommendations
Diagnosis
Management
- Remove unsupported claims about monitoring plasma PZP concentrations.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Remove unsupported claims about elevated PZP levels indicating the need for intervention.
Clinical Best Practices
- Remove the suggestion to utilize plasma PZP levels as a biomarker unless sourced.
Related Resources & Content
